A Prospective, Pilot Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in HLA Sensitized Kidney Transplant Recipients

Trial Profile

A Prospective, Pilot Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in HLA Sensitized Kidney Transplant Recipients

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Jun 2017

At a glance

  • Drugs Tacrolimus (Primary) ; Alemtuzumab; Immune globulin; Mycophenolate mofetil; Mycophenolate sodium; Prednisone; Rituximab
  • Indications Transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top